Phase 3 Clinical Trial of mRNA Vaccine Against Norovirus

For demographics: Seniors

Thank you for your interest in participating in our studies. This study is now closed. To see a list of available studies, click here.

Purpose

This is a phase 3 study. We are looking to test the safety and effectiveness of mRNA-1403 vaccine for Norovirus.

About Norovirus

Norovirus is an infection that can cause sudden diarrhea and vomiting (commonly referred to as acute gastroenteritis). Symptoms may also include nausea, stomach pain, headache and chills, usually lasting for 1 to 3 days. In severe cases, these symptoms can lead to dehydration, which may require hospitalization or IV fluids.

Participation Criteria

You can take part in this study if you are:

70+ years of age
In good health

Participation Details

This study has 6 clinic visits and approximately 6 safety telephone calls over approximately 18 months. There are 3 study injections in the first 6 months.

You will be financially compensated for your time.

More studies:

No studies found matching your criteria